Chen_2019_Alzheimers.Dement.(N.Y)_5_38

Reference

Title : The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine-A randomized, double-blind, placebo-controlled trial - Chen_2019_Alzheimers.Dement.(N.Y)_5_38
Author(s) : Chen CLH , Sharma PR , Tan BY , Low C , Venketasubramanian N
Ref : Alzheimers Dement (N Y) , 5 :38 , 2019
Abstract : Chen_2019_Alzheimers.Dement.(N.Y)_5_38
ESTHER : Chen_2019_Alzheimers.Dement.(N.Y)_5_38
PubMedSearch : Chen_2019_Alzheimers.Dement.(N.Y)_5_38
PubMedID: 30723778

Related information

Citations formats

Chen CLH, Sharma PR, Tan BY, Low C, Venketasubramanian N (2019)
The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine-A randomized, double-blind, placebo-controlled trial
Alzheimers Dement (N Y) 5 :38

Chen CLH, Sharma PR, Tan BY, Low C, Venketasubramanian N (2019)
Alzheimers Dement (N Y) 5 :38